PEC vs TSH Biopharm: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and TSH Biopharm (8432) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ TSH Biopharm

0%+108%-36%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYTSH BiopharmYoY
Oct 2026NT$2.84 billion+102.0%NT$168.9 million+19.3%
Sep 2026NT$2.64 billion+100.0%NT$325.4 million+34.1%
Aug 2026NT$2.62 billion+105.4%NT$124.8 million+30.9%
Jul 2026NT$2.51 billion+92.6%NT$107 million+26.6%
Jun 2026NT$2.33 billion+94.9%NT$96.3 million+6.4%
May 2026NT$2.46 billion+108.5%NT$126.1 million+34.5%
Apr 2026NT$2.06 billion+68.3%NT$108.4 million+27.4%
Mar 2026NT$1.94 billion+64.4%NT$108.8 million+15.6%
Feb 2026NT$1.6 billion+56.7%NT$70 million-35.9%
Jan 2026NT$1.58 billion+49.8%NT$107 million+27.7%
Dec 2025NT$1.92 billion+69.9%NT$105.7 million+4.2%
Nov 2025NT$1.55 billion+53.0%NT$118 million+28.3%
Oct 2025NT$1.4 billion+53.6%NT$141.6 million+45.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16